Vapotherm, Inc. (VAPO) |
| 2.17 -0.01 (-0.46%) 09-19 15:20 |
| Open: | 2.17 |
| High: | 2.17 |
| Low: | 2.17 |
| Volume: | 28,038 |
| Market Cap: | 14(M) |
| PE Ratio: | -0.26 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 167.87 |
| Resistance 1: | 143.72 |
| Pivot price: | 134.93 |
| Support 1: | 126.64 |
| Support 2: | 116.08 |
| 52w High: | 3.44 |
| 52w Low: | 0.6999 |
Vapotherm, Inc. is a medical technology company focused on creating and selling its unique high-velocity therapy products. These devices are designed to assist patients of all ages who are experiencing respiratory distress, with sales reaching both domestic and international markets. The company's primary offerings include its "Precision Flow" system lineup, featuring models such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox. These innovative systems deliver heated, humidified, and oxygen-enriched air at a high flow rate directly to patients through small-bore nasal interfaces. Beyond its core systems, Vapotherm also supplies a variety of essential accessories. The Vapotherm Transfer Unit enables patients to be moved between hospital areas or walk around while continuing their therapy. A Q50 compressor is available to provide the necessary compressed air for the Precision Flow systems. For medication delivery, the company offers an aerosol aeroneb adaptor, facilitating the provision of ultrasonic aerosolized medication, as well as an aerosol disposable patient circuit designed to streamline both continuous and intermittent aerosol drug administration. Tracheostomy adaptors are also part of their product range. Furthermore, Vapotherm manufactures ProSoft cannulas, engineered for comfortable skin contact, alongside various disposable items, including single-use components and nasal interfaces. Clinicians can also utilize Oxygen Assist Modules, which aid in keeping patient oxygen levels within a desired therapeutic range. The company distributes its medical products predominantly to hospitals. Vapotherm, Inc. was founded in 1993 and is based in Exeter, New Hampshire.
| EPS | 2.810 |
| Book Value | 34.040 |
| PEG Ratio | 0.61 |
| Gross Profit | 21.794 |
| Profit Margin (%) | 5.27 |
| Operating Margin (%) | 21.95 |
| Return on Assets (ttm) | 0.9 |
| Return on Equity (ttm) | 11.4 |
Fri, 20 Sep 2024
Vapotherm Announces Closing of Merger - PR Newswire
Mon, 17 Jun 2024
Vapotherm enters merger deal that will take company private - MassDevice
Mon, 17 Jun 2024
Vapotherm Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going Private - PR Newswire
Thu, 13 Oct 2022
New York Stock Exchange issues delisting warning to Vapotherm - NH Business Review
Sat, 10 Sep 2022
Vapotherm [NYSE: VAPO] | Top Respiratory Devices Solution Company 202 - MedTech Outlook
Thu, 03 Mar 2022
Vapotherm Launches Strategic AI Program Partnership With Carnegie Mellon - Tepper School of Business - Carnegie Mellon University
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |